Life Sciences Boot Camp for In-House Counsel 2024 | San Francisco - McDermott Will & Emery

Life Sciences Boot Camp for In-House Counsel 2024 | San Francisco

Overview


As life sciences companies continue to grapple with increasingly complex and continuously evolving legal, business and regulatory issues, McDermott is pleased to bring our Life Sciences Boot Camp for In-House Counsel back to the Bay Area!

Join our cross-functional team of industry-focused life sciences lawyers for a half-day of CLE programming addressing the current state of the industry and the most pressing issues facing in-house counsel today – plus multiple networking opportunities with you in-house peers.

FEATURED SESSIONS INCLUDE:

  • IP Litigation: Things You Don’t Want to Wish You’d Thought About Earlier: Explore recent developments in patent litigation that can cause unexpected stress and concern when not considered early in the process. Evaluate the surge in utilizing prosecution laches as a defensive weapon in patent disputes through the lens of new US case law addressing this tactic. Have a trade show in the United States and want to bring samples of a prototype medical product? Might that trip buy you a first-class ticket to a patent lawsuit? Find out the things we litigators stress about so our clients can rest easy. Attendees will receive actionable strategies for protecting patent rights amidst evolving legal tactics.
  • Life Sciences Licensing, M&A and Other Corporate Transactional Trends in 2024: Get timely updates pertaining to growing trends in essential business domains, including mergers and acquisitions (M&A), pre-initial public offering preparation and general corporate matters. Engage in nuanced discussions covering licensing, contract dynamics, governance structures, strategic financing and M&A tactics, curated to deliver invaluable insights for corporate success in the life sciences sector.
  • Lowering Regulatory Barriers to Market Access: FDA and Reimbursement for Therapeutics, Devices, Diagnostics and Digital Health: Uncover strategies to lower the regulatory burden for various medical product types from a US Food and Drug Administration (FDA) standpoint. Explore a mix of recent FDA and Centers for Medicare & Medicaid Services policies and upcoming developments, including federal drug pricing initiatives, alongside recent efforts by life sciences and digital health companies to challenge regulatory bodies.
  • Hot Topics in Life Sciences Employment Law: Dive into the dynamic landscape of employment law with an exploration of hot topics and emerging trends in the life sciences industry. Learn about the key issues impacting employment and compliance in the industry this year. Topics include employee mobility issues; recent changes in federal and state laws, regulations, and court decisions; and new 2024 compliance issues.

Agenda


12:00 – 1:00 pm (PDT)
Registration & Networking Lunch

1:10 – 2:05 pm (PDT)
IP Litigation: Things You Don’t Want to Wish You’d Thought About Earlier

2:05 – 3:00 pm (PDT)
Life Sciences Licensing, M&A and Other Corporate Transactional Trends in 2024

3:10 – 4:05 pm (PDT)
Lowering Regulatory Barriers to Market Access: FDA and Reimbursement for Therapeutics, Devices, Diagnostics and Digital Health

4:05 – 5:00 pm (PDT)
Hot Topics in Life Sciences Employment Law

5:00 – 6:00 pm (PDT)
Networking Reception

Dig Deeper